Article
The radiological characteristics, tertiary lymphoid structures, and survival status associated with EGFR mutation in patients with subsolid nodules like stage I-II LUAD.
BMC cancer - 25 Mar 2024
Xie Mei, Gao Jie, Ma Xidong, Song Jialin, Wu Chongchong, Zhou Yangyu, Jiang Tianjiao, Liang Yiran, Yang Chen, Bao Xinyu, Zhang Xin, Yao Jie, Jing Ying, Wu Jianlin, Wang Jianxin, Xue Xinying
Abstract excerpt
BACKGROUND: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) recommended for the patients with subsolid nodule in early lung cancer stage is not routinely. The clinical value and impact in patients with EGFR mutation on survival outcomes is further needed to be elucidated to decide whether the application of EGFR-TKIs was appropriate in early lung adenocarcinoma (LUAD) stage appearing as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.